Bilaketaren emaitzak

Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial nork Panagiotis Kottaridis, Janet North, Maria Tsirogianni, Chloë Marden, Edward Samuel, Sam Jide-Banwo, Sarah Grace, Mark W. Lowdell

Testu osoa Testu osoa

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia nork Davide Rossi, Lodovico Terzi-di-Bergamo, Lorenzo De Paoli, Michaela Cerri, Guido Ghilardi, Annalisa Chiarenza, Pietro Bulian, Carlo Visco, Francesca Romana Mauro, Fortunato Morabito, Agostino Cortelezzi, Francesco Zaja, Francesco Forconi, Luca Laurenti, Ilaria Del Giudice, Massimo Gentile, Iolanda Donatella Vincelli, Marina Motta, Marta Coscia, Gian Matteo Rigolin, Alessandra Tedeschi, Antonino Neri, Roberto Marasca, Omar Perbellini, Carol Moreno, Giovanni Del Poeta, Massimo Massaia, Pier Luigi Zinzani, Marco Montillo, Antonio Cuneo, Valter Gattei, Robin Foà, Gianluca Gaïdano

Testu osoa Testu osoa

Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia nork Upendra P. Hegde, Wyndham H. Wilson, Therese White, Bruce D. Cheson

Testu osoa Testu osoa

Fludarabine therapy in macroglobulinemic lymphoma nork HM Kantarjian, Raymond Alexanian, CA Koller, Razelle Kurzrock, MJ Keating

Testu osoa Testu osoa

p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies nork Eric Wattel, Claude Preudhomme, B Hecquet, M Vanrumbeke, Bruno Quesnel, I Dervite, Pierre Morel, Pierre Fenaux

Testu osoa Testu osoa

p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias nork H. Döhner, Konstanze Fischer, Martin Bentz, Klavs Würgler Hansen, Axel Benner, G Cabot, Daniela Diehl, Richard F. Schlenk, Johannes Coy, Stephan Stilgenbauer, Martin Volkmann, Peter R. Galle, Albert J. Poustka, W. Hunstein, Peter Lichter

Testu osoa Testu osoa

Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy nork Sergio Giralt, Elihu H. Estey, Maher Albitar, Koen van Besien, Gabriela Rondón, Paolo Anderlini, Susan O’Brien, Issa F. Khouri, James Gajewski, Rakesh Mehra, David F. Claxton, Börje S. Andersson, Miloslav Beran, Donna Przepiorka, Charles Koller, Steve Kornblau, Martin Körbling, Michael J. Keating, Hagop M. Kantarjian, Richard E. Champlin

Testu osoa Testu osoa

Reduced‐intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: A report from the <scp>A</scp>cute <scp>L</s... nork Frédéric Baron, Myriam Labopin, Andy Peniket, Pavel Jindra, Boris V. Afanasyev, Miguel Á. Sanz, Éric Deconinck, Arnon Nagler, Mohamad Mohty

Testu osoa

Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment [see c... nork S O'Brien, Hagop M. Kantarjian, Miloslav Beran, Terry Smith, Charles Koller, Elihu H. Estey, L. E. Robertson, Susan Lerner, Michael J. Keating

Testu osoa Testu osoa

Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. nork David J. McConkey, Joya Chandra, Susan Wright, William Plunkett, Timothy J. McDonnell, John C. Reed, M Keating

Testu osoa Testu osoa

Radiation-sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation—what to do? nork Morton J. Cowan, Andrew R. Gennery

Testu osoa

Toxoplasmose e transfusão de sangue nork Luiz Amorim

Testu osoa Testu osoa

Results of an outpatient‐based stem cell allotransplant program using nonmyeloablative conditioning regimens nork Guillermo J. Ruíz‐Argüelles, David Gómez‐Almaguer, Alejandro Ruı́z-Argüelles, Óscar González‐Llano, Olga G. Cantú, José Carlos Jaime‐Pérez

Testu osoa Testu osoa

Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60–78 years of age nork Scott Samuelson, Brenda M. Sandmaier, Helen E. Heslop, Uday Popat, George Carrum, Richard E. Champlin, Rainer Storb, Josef T. Prchal, Theodore A. Gooley, H. Joachim Deeg

Testu osoa Testu osoa

Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia nork Sarit Assouline, Valéria Buccheri, Alain Delmer, Gianluca Gaïdano, Christine McIntyre, Michael Brewster, Olivier Catalani, Florence Hourcade‐Potelleret, Pakeeza Sayyed, Xavier C. Badoux

Testu osoa Testu osoa

Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update nork Andrea Bacigalupo, Alida Dominietto, Anna Ghiso, Carmen Di Grazia, Teresa Lamparelli, Francesca Gualandi, Stefania Bregante, Maria Teresa Van Lint, Simona Geroldi, Silvia Luchetti, Rosario Francesco Grasso, Sarah Pozzi, Nicoletta Colombo, Elisabetta Tedone, Riccardo Varaldo, Anna Maria Raiola

Testu osoa Testu osoa

Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell... nork Johannes Clausen, Dominik Wolf‎, Andreas Petzer, Eberhard Gunsilius, Paul Schumacher, Brigitte Kircher, Günther Gastl, David Nachbaur

Testu osoa Testu osoa

Chlorambucil plus rituximab with or without maintenance rituximab as first‐line treatment for elderly chronic lymphocytic leukemia patients nork Robin Foà, Ilaria Del Giudice, Antonio Cuneo, Giovanni Del Poeta, Stefania Ciolli, Francesco Di Raimondo, Francesco Lauria, Emanuele Cencini, Gian Matteo Rigolin, Agostino Cortelezzi, Francesco Nobile, Vincenzo Callea, Maura Brugiatelli, Massimo Massaia, Stefano Molica, Livio Trentin, Rita Rizzi, Giorgina Specchia, Francesca Di Serio, Lorella Orsucci, Achille Ambrosetti, Marco Montillo, Pier Luigi Zinzani, Felicetto Ferrara, Fortunato Morabito, Maria Angela Mura, S Soriani, Nadia Peragine, Simona Tavolaro, Silvia Bonina, M Marinelli, Maria Stefania De Propris, Irene Della Starza, Alfonso Piciocchi, A. Alietti, Eva J. Runggaldier, Enrica Gamba, Francesca Romana Mauro, Sabina Chiaretti, Anna Guarini

Testu osoa Testu osoa

A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine nork Elisabeth Walsby, Guy Pratt, Hao Shao, Abdullah Y. Abbas, Peter M. Fischer, Tracey D. Bradshaw, Paul Brennan, Chris Fegan, Shudong Wang, Chris Pepper

Testu osoa Testu osoa

Initial treatment of CLL: integrating biology and functional status nork Nitin Jain, Susan O’Brien

Testu osoa Testu osoa